Description:
NIEMANN-PICK DISEASE, TYPE C1; NPC1
NPC1 GENE; NPC1
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Lysosomal Storage Diseases |
Class |
Disorders of Lipid Metabolism |
Cell Type
|
Fibroblast
|
Transformant
|
Untransformed
|
Relation to Proband
|
proband
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase,Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis |
|
Gene |
NPC1 |
Chromosomal Location |
18q11-q12 |
Allelic Variant 1 |
D242H; NIEMANN-PICK DISEASE, TYPE C1 |
Identified Mutation |
ASP242HIS |
|
Gene |
NPC1 |
Chromosomal Location |
18q11-q12 |
Allelic Variant 2 |
S940L; NIEMANN-PICK DISEASE, TYPE C1 |
Identified Mutation |
SER940LEU |
Remarks |
Clinically affected; fibroblasts showed no detectable activity in a cholesterol esterification assay; a complementation test showed that the cells were scored as "other" [see Park et al. Hum Mut 22:313-325 (2003)]; the donor subject is a compound heterozygote at the NPC1 gene locus: allele 1 carries a substitution (G>C) at nucleotide 724 (c.724G>C) in exon 6, resulting in a missense mutation at codon 242 [D242H (ASP242HIS)]; allele 2 carries a substitution (C>T) at nucleotide 2819 (c.2819C>T) in exon 19, resulting in a missense mutation at codon 940 [S940L (SER940LEU)]; the subject also carries the following polymorphisms: (T>C) at nucleotide 387 (387T>C) resulting in a silent mutation (Y>Y) at codon 129 [Y129Y, (TYR129TYR)]; (A>G) at nucleotide 644 (644A>G) resulting in a missense mutation (H>R) at codon 215 [H215R (HIS215ARG)]; (A>G) at nucleotide 2572 (c.2572A>G) resulting in a missense mutation (I>V) at codon 858 [I858V (ILE858VAL)]; the first nucleotide of the initiating MET codon is numbered +1. |
Split Ratio |
1:2 |
Temperature |
37 C |
Percent CO2 |
5% |
Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not inactivated |
Substrate |
None specified |
Subcultivation Method |
trypsin-EDTA |
Supplement |
- |
|
|